Concentrix SEC Filings

Concentrix (CNXC) insider filing reports two transactions by the company’s President and CEO, who also serves as a Director. On 10/29/2025, the reporting person made a bona fide gift of 20,684 shares of common stock at $0, described as a transfer to a family trust in which the reporting person has no beneficial or pecuniary interest. Following this gift, the filing shows 284,661 shares held directly.

On 10/30/2025, the reporting person purchased 2,000 common shares at an average price of $42.0279, bringing direct beneficial ownership to 286,661 shares. Both holdings are reported as Direct (D) ownership.

Concentrix Corp (CNXC) reported an insider transaction by its EVP, Global Ops & Delivery. On October 30, 2025, the officer sold 500 shares of common stock at $42.53 per share. The filing states the sale was effected pursuant to a Rule 10b5-1 trading plan adopted on January 28, 2025.

Following this transaction, the reporting person beneficially owns 35,630 shares, held directly. This is a routine Form 4 disclosure of an executive’s equity transaction under a pre-established plan.

Concentrix (CNXC)code F disposition of 1,403 shares of common stock at $46.04. After this transaction, the reporting person directly beneficially owns 41,008 shares. The filer is listed as EVP, Global Sales, Acct Mgmt, and the filing was made by one reporting person.

Concentrix (CNXC) reported an insider share purchase by its President & CEO, who is also a Director. On 10/10/2025, the executive bought 1,000 shares of common stock at $45.35 per share (transaction code P). Following the transaction, the executive beneficially owns 305,345 shares, held directly.

Christopher A. Caldwell, President and CEO and Director of Concentrix Corp (CNXC), reported a sale of common stock on 10/07/2025. The filing shows 390 shares were sold at $47.76, leaving Mr. Caldwell with 304,345 shares held directly after the transaction. The Form 4 was signed by an attorney-in-fact on 10/09/2025. No options or derivative transactions were reported.

Jane Fogarty, Executive Vice President, Legal at Concentrix Corp (CNXC), reported a sale of company stock on 10/05/2025. The Form 4 shows 126 shares sold at a price of $48.26 per share, leaving 19,131 shares beneficially owned directly after the transaction. The filing is signed by an attorney-in-fact on 10/07/2025.

Concentrix Corporation presents interim unaudited consolidated financial statements prepared in accordance with SEC rules and GAAP with normal recurring adjustments. The filing discloses 69,120 and 68,849 shares issued as of August 31, 2025 and November 30, 2024, and 62,209 and 64,238 shares outstanding on those dates. The Company reports accounts receivable activity under factoring programs, with $127,000 outstanding at August 31, 2025 and sales of $328,000 during the three months ended August 31, 2024. In connection with the Webhelp acquisition, Concentrix recorded cross-currency interest rate swaps on $500,000 of senior notes to synthetically convert $250,000 of 2026 notes and $250,000 of 2028 notes into euro-based debt at weighted rates of 5.12% and 5.18%, respectively. Term loan principal outstanding decreased to $1,350,000 at August 31, 2025 from $1,500,000 on November 30, 2024, after voluntary prepayments of $150,000 in the nine months. The company amended its credit facilities (Restated Credit Agreement) providing multiple term and delayed-draw facilities and a $1.1 billion revolving credit capacity. The Securitization Facility commitment was increased to $700,000. Concentrix repurchased 2,247 shares for $112,774 in the nine months ended August 31, 2025 and reports approximately $495,402 remaining under its repurchase authorization. Pension plans were underfunded by $81,974 at August 31, 2025. The Company states it was in compliance with covenant requirements as of August 31, 2025.

Concentrix Corp director and President/CEO Christopher A. Caldwell reported three transactions on 09/30/2025. He acquired 1,000 shares of Common Stock at $47.435, exercised 9,363 employee stock options with an exercise price of $44.52, and had 8,990 shares withheld to satisfy the option exercise price and taxes. After these transactions the reported beneficial ownership totals shown on the form include 313,725 and similar post-transaction balances for direct holdings.

Twomey Cormac J, Executive Vice President, Global Ops & Delivery at Concentrix Corp (CNXC), reported a sale of 500 shares of the issuer's common stock on 09/30/2025 at a price of $47.08 per share. The filing states the sale was effected pursuant to a Rule 10b5-1 trading plan established on January 28, 2025. After the reported transaction the reporting person beneficially owns 36,130 shares, held directly. The Form 4 was filed as a single-person filing and bears an attorney-in-fact signature dated 10/02/2025.